Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback